Onyx Biotec Limited IPO

Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures Sterile Water for Injections and serves as a pharmaceutical contract manufacturer, offering a comprehensive range of Dry Powder Injections and Dry Syrups for both the Indian and overseas markets.

The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has a daily production capacity of 638,889 units of Sterile Water for Injections, while Unit II produces 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.

The company clientele includes Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others.

As of May 31, 2024, the company had a client base of more than 100 Indian and multinational pharmaceutical companies.

The company has received certificates for the management system, ISO 9001:2015, and ISO 14001:2015 from ROHS Certification Private Limited.

As of July 31, 2024, the company has 175 employees across various departments.

 

Onyx Biotec Limited Financial Information (Restated)

Onyx Biotec Limited’s revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 May 202431 Mar 202431 Mar 202331 Mar 2022
Assets7,476.577,413.585,872.363,683.84
Revenue1,054.115,387.433,961.654,498.09
Profit After Tax130.77303.16184.46335.29
Net Worth2,618.642,487.871,820.161,637.59
Reserves and Surplus1,286.421,155.651,230.001,047.43
Total Borrowing3,156.143,078.042,922.831,224.39
Amount in ₹ Lakhs

Key Performance Indicator

The market capitalization of Onyx Biotec IPO is Rs 110.61 Cr.

KPI as of May 31, 2024.

KPIValues
ROE4.99%
ROCE3.71%
Debt/Equity1.21
RoNW4.99%
P/BV3.1
PAT Margin (%)12.42
 Pre IPOPost IPO
EPS (Rs) 2.284.33
P/E (x) 26.8114.1
Note:
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of May 31, 2024 that is available in RHP.

Objects of the Issue (Onyx Biotec IPO Objectives)

The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:

  1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;
  2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;
  3. Prepayment or repayment of all or a portion of certain loans availed by the Company; and
  4. General Corporate Purposes.

Onyx Biotec IPO Details

IPO DateNovember 13, 2024 to November 18, 2024
Listing Date[.]
Face Value₹10 per share
Price Band₹58 to ₹61 per share
Lot Size2000 Shares
Total Issue Size4,810,000 shares
(aggregating up to ₹29.34 Cr)
Fresh Issue4,810,000 shares
(aggregating up to ₹29.34 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Share holding pre issue13,322,200
Share holding post issue18,132,200
Market Maker portion244,000 shares

Onyx Biotec IPO Promoter Holding

The Promoters of the company are Sanjay Jain, Naresh Kumar and Fateh Pal Singh.

Share Holding Pre Issue88.60%
Share Holding Post Issue 

SHARIAH SCREENING for - Onyx Biotec Limited IPO

Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.

Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.

BUSINESS SCREEN

FINANCIAL RATIOS

As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in

Spread the Knowledge - Share the Latest IPO Updates and Shariah Compliant IPO's.

Latest Current & Upcoming IPOs in BSE & NSE - Including Shariah Compliant.

The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.

IPO

Onyx Biotec Limited IPO Detail

Last Updated on November 12, 2024 Onyx Biotec Limited IPO Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections. The company currently manufactures

Read More »
IPO

Mangal Compusolution Limited IPO Detail

Last Updated on November 11, 2024 Mangal Compusolution Limited IPO Incorporated in April 2011, Mangal Compusolution Limited provides hardware rental solutions to fulfill the needs of businesses across various industries.

Read More »

Dear Halal Stock Users,

If you believe our website is a valuable resource,
we invite you to support us.
Your contribution ensures free access for all
and fuels future development.

You can contribute as little as
100, 200, 500 & so…
every bit counts.

Thank you for your support!